# Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)

> **NCT03147638** · PHASE3 · UNKNOWN · sponsor: **Marshall University** · enrollment: 70 (estimated)

## Conditions studied

- Heparin-induced Thrombocytopenia

## Interventions

- **DRUG:** Warfarin, NOAC

## Key facts

- **NCT ID:** NCT03147638
- **Lead sponsor:** Marshall University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-11
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03147638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03147638, "Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03147638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*